Cargando…

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

BACKGROUND: Treatment-emergent neuroendocrine prostate cancer (NEPC) after androgen receptor (AR) targeted therapies is an aggressive variant of prostate cancer with an unfavorable prognosis. The underlying mechanisms for early neuroendocrine differentiation are poorly defined and diagnostic and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Shu, Zhao, Jinge, Lombard, Alan P., D’Abronzo, Leandro S., Leslie, Amy R., Sharifi, Masuda, Lou, Wei, Liu, Chengfei, Yang, Joy C., Evans, Christopher P., Corey, Eva, Chen, Hong-Wu, Yu, Aiming, Ghosh, Paramita M., Gao, Allen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492734/ https://www.ncbi.nlm.nih.gov/pubmed/36159187 http://dx.doi.org/10.1038/s43856-022-00182-9

Ejemplares similares

eIF4E Phosphorylation in Prostate Cancer()()
por: D'Abronzo, Leandro S., et al.
Publicado: (2018)

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()
por: Lombard, Alan P, et al.
Publicado: (2019)

Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
por: Jathal, Maitreyee K., et al.
Publicado: (2019)

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase
por: Jathal, Maitreyee K., et al.
Publicado: (2023)

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
por: Liu, Chengfei, et al.
Publicado: (2021)

Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity
por: Monga, Jitender, et al.
Publicado: (2021)

Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer
por: Schaaf, Zachary A., et al.
Publicado: (2023)

The Androgen Receptor is a negative regulator of eIF4E Phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer
por: D’Abronzo, Leandro S., et al.
Publicado: (2017)

Immune evasion strategies of neuroendocrine-like Enzalutamide resistant prostate cancer
por: Bishop, Jennifer L, et al.
Publicado: (2013)

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
por: Xu, Pengfei, et al.
Publicado: (2023)

Linking mechanistic and behavioral responses to sublethal esfenvalerate exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae)
por: Connon, Richard E, et al.
Publicado: (2009)

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
por: Lee, Geun Taek, et al.
Publicado: (2019)

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
por: Westbrook, Thomas C., et al.
Publicado: (2022)

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
por: Xu, Pengfei, et al.
Publicado: (2023)

ARHGEF26 enhances Salmonella invasion and inflammation in cells and mice
por: Bourgeois, Jeffrey S., et al.
Publicado: (2021)

Impairment of social behaviors in Arhgef10 knockout mice
por: Lu, Dai-Hua, et al.
Publicado: (2018)

ARHGEF17 sets the timer for retention of Mps1 at kinetochores
por: Marquardt, Joseph R., et al.
Publicado: (2016)

ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation
por: Alber, Michael, et al.
Publicado: (2017)

ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma
por: Gong, Jie, et al.
Publicado: (2021)

SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume
por: Zou, Siying, et al.
Publicado: (2017)

ArhGEF37 assists dynamin 2 during clathrin-mediated endocytosis
por: Viplav, Abhiyan, et al.
Publicado: (2019)

ARHGEF11, a regulator of junction-associated actomyosin in epithelial cells
por: Itoh, Masahiko
Publicado: (2013)

Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis
por: Qasim, Hanan, et al.
Publicado: (2019)

ARHGEF38 as a novel biomarker to predict aggressive prostate cancer
por: Liu, Kun, et al.
Publicado: (2019)

Role of ARHGEF3 as a GEF and mTORC2 Regulator
por: Khaliq, Sana Abdul, et al.
Publicado: (2022)

ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer
por: Zhou, Feifei, et al.
Publicado: (2022)

ARHGEF3 Regulates Skeletal Muscle Regeneration and Strength through Autophagy
por: You, Jae-Sung, et al.
Publicado: (2021)

Novelties in Imaging of Thoracic Sarcoidosis
por: Calandriello, Lucio, et al.
Publicado: (2021)

Clinical Pharmacokinetic Studies of Enzalutamide
por: Gibbons, Jacqueline A., et al.
Publicado: (2015)

Esrp1-Regulated Splicing of Arhgef11 Isoforms Is Required for Epithelial Tight Junction Integrity
por: Lee, SungKyoung, et al.
Publicado: (2018)

hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro
por: Lim, Marvin C. J., et al.
Publicado: (2021)

ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells
por: Lei, Xiong, et al.
Publicado: (2018)

Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation
por: Ravindran, Ethiraj, et al.
Publicado: (2017)

FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells
por: Yu, Bei, et al.
Publicado: (2020)

Arhgef5 Binds α-Dystrobrevin 1 and Regulates Neuromuscular Junction Integrity
por: Bernadzki, Krzysztof M., et al.
Publicado: (2020)

Transgenerational Obesity and Alteration of ARHGEF11 in the Rat Liver Induced by Intrauterine Hyperglycemia
por: Zhang, Wanyi, et al.
Publicado: (2019)

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion
por: Kurozumi, Kazuhiko, et al.
Publicado: (2022)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
por: Kawahara, Takashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ralcp5ss18cj3ei1m60g4em3tf